United States Phosphodiesterase Inhibitor Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 122

Notes:

Sales, means the sales volume of Phosphodiesterase Inhibitor

Revenue, means the sales value of Phosphodiesterase Inhibitor

This report studies sales (consumption) of Phosphodiesterase Inhibitor in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Actelion Pharmaceuticals Ltd.

- United Therapeutics Corporation

- Gilead sciences

- Bayer AG

- SteadyMed Ltd.

- GlaxoSmithKline plc

- Pfizer Inc.

- Reata Pharmaceuticals Inc.

- Arena Pharmaceuticals Inc.

- Merck & Co. Inc

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Phosphodiesterase Inhibitor in each application, can be divided into

- Health care

- Clinic

- Hospital

United States Phosphodiesterase Inhibitor Market Report 2016

Table of Contents
United States Phosphodiesterase Inhibitor Market Report 2016
1 Phosphodiesterase Inhibitor Overview
1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Classification of Phosphodiesterase Inhibitor
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Phosphodiesterase Inhibitor
1.3.1 Health care
1.3.2 Clinic
1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Phosphodiesterase Inhibitor (2011-2021)
1.4.1 USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)
1.4.2 USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)
2 USA Phosphodiesterase Inhibitor Competition by Manufacturers
2.1 USA Phosphodiesterase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Phosphodiesterase Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Phosphodiesterase Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Phosphodiesterase Inhibitor Market Competitive Situation and Trends
2.4.1 Phosphodiesterase Inhibitor Market Concentration Rate
2.4.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Phosphodiesterase Inhibitor Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Type (2011-2016)
3.2 USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)
3.3 USA Phosphodiesterase Inhibitor Price by Type (2011-2016)
3.4 USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)
4 USA Phosphodiesterase Inhibitor Sales (Volume) by Application (2011-2016)
4.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Application (2011-2016)
4.2 USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Phosphodiesterase Inhibitor Manufacturers Profiles/Analysis
5.1 Actelion Pharmaceuticals Ltd.
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
5.2.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Gilead sciences
5.3.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer AG
5.4.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
5.5.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
5.6.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
5.7.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
5.8.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
5.9.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
5.10.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Phosphodiesterase Inhibitor Manufacturing Cost Analysis
6.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Phosphodiesterase Inhibitor Market Forecast (2016-2021)
10.1 USA Phosphodiesterase Inhibitor Sales, Revenue Forecast (2016-2021)
10.2 USA Phosphodiesterase Inhibitor Sales Forecast by Type (2016-2021)
10.3 USA Phosphodiesterase Inhibitor Sales Forecast by Application (2016-2021)
10.4 Phosphodiesterase Inhibitor Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Phosphodiesterase Inhibitor
Table Classification of Phosphodiesterase Inhibitor
Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Type in 2015
Table Application of Phosphodiesterase Inhibitor
Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)
Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)
Table USA Phosphodiesterase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table USA Phosphodiesterase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Table USA Phosphodiesterase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2015
Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers
Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers
Table USA Phosphodiesterase Inhibitor Sales by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales Share by Type (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Market Share by Type in 2015
Table USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Price by Type (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales by Application (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales Market Share by Application (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Market Share by Application in 2015
Table USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure USA Phosphodiesterase Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table USA Phosphodiesterase Inhibitor Production Forecast by Type (2016-2021)
Table USA Phosphodiesterase Inhibitor Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Tumor Marker Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Tumor Marker Revenue, means the sales value of Tumor Marker This report studies sales (consumption) of Tumor Marker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott - Siemens - Alere - Johnson - BD - Nova - ... Market Segment by States, covering - California - Texas......
  • United States Mildronate Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Mildronate Revenue, means the sales value of Mildronate This report studies sales (consumption) of Mildronate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Psypharm - Latvian company - Jinan Chenghui-shuangda Chemical - Canadian Pharmacy - Grindex company - Slovakia - United Pharmacies - chemBli......
  • United States Argatroban Powder Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Argatroban Powder Revenue, means the sales value of Argatroban Powder This report studies sales (consumption) of Argatroban Powder in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer, Inc - SANDOZ - GlaxoSmithKline Plc - fresenius-kabi - Eagle Pharmaceuticals, Inc - Mitsubishi Tanabe Pharma - Teva Ph......
  • Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Boehringer Ingelheim?......
  • Global Finasteride Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 113
    Notes: Sales, means the sales volume of Finasteride Revenue, means the sales value of Finasteride This report studies sales (consumption) of Finasteride in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Merck - Actavis - Sandoz - Teva Pharmaceuticals - Cipla - RelonC......
  • China HIV Drugs Market Research Report 2017
    Published: 21-Feb-2017        Price: US 3200 Onwards        Pages: 116
    Notes: Sales, means the sales volume of HIV Drugs Revenue, means the sales value of HIV Drugs This report studies HIV Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bristol-Myers Squibb - Gilead Sciences - GSK - Johnson - Merck - AbbVie - AstraZeneca - Boehringer Ingelheim - Cipla - Daii......
  • China Medicinal Vaseline Market Research Report 2017
    Published: 21-Feb-2017        Price: US 3200 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Medicinal Vaseline Revenue, means the sales value of Medicinal Vaseline This report studies Medicinal Vaseline in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Company 1 - Company 2 - Company 3 - Company 4 - Company 5 - Company 6 - Company 7 - Company 8 - Company......
  • Europe Trazodone Market Report 2017
    Published: 21-Feb-2017        Price: US 3900 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Trazodone Revenue, means the sales value of Trazodone This report studies sales (consumption) of Trazodone in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Teva - Angelini - Mylan - Fermion - The Piramal Group ......
  • Europe Tranylcypromine Market Report 2017
    Published: 21-Feb-2017        Price: US 3900 Onwards        Pages: 127
    Notes: Sales, means the sales volume of Tranylcypromine Revenue, means the sales value of Tranylcypromine This report studies sales (consumption) of Tranylcypromine in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Teva - Emcure - Novartis - Mylan -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs